Eli Lilly and CompanyLLYNYSE
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$414.30M
↓ 84% below average
Average (9y)
$2.63B
Historical baseline
Range
High:$5.39B
Low:$-3.15B
CAGR
-12.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $414.30M | +113.1% |
| 2023 | $-3.15B | -168.5% |
| 2022 | $4.60B | -14.6% |
| 2021 | $5.39B | +20.5% |
| 2020 | $4.47B | +28.3% |
| 2019 | $3.48B | +39.0% |
| 2018 | $2.51B | -27.4% |
| 2017 | $3.45B | -8.2% |
| 2016 | $3.76B | +180.9% |
| 2015 | $1.34B | - |